Shuiying Hu

4.8k citations
94 papers · 3.5k indexed · h-index 32
Topics
Drug Transport and Resistance Mechanisms (44 papers)Pharmacogenetics and Drug Metabolism (17 papers)Cancer Treatment and Pharmacology (16 papers)

In The Last Decade

Shuiying Hu

89 papers receiving 3.4k citations

Peers

Shuiying Hu
Comparison fields: 5 of 118
  • Oncology 1.7k
  • Molecular Biology 1.3k
  • Endocrinology, Diabetes and Metabolism 696
  • Hematology 505
  • Pediatrics, Perinatology and Child Health 406
Replace Kenichi Furihata with:
Kenichi Furihata Japan
Douglas K. Price United States
Piter J. Bosma Netherlands
Sumio Kawata Japan
Helen L. Reeves United Kingdom
Cody J. Peer United States
Andrew G. Hall United Kingdom
Tristan M. Sissung United States
Raymond J. Hohl United States
Jacques Jolivet Canada
Shuiying Hu relative to Kenichi Furihata Japan Kenichi Furihata's profile →
Citations per field
00.5×2.5×
Kenichi Furihata · 1×
Citations per year

Countries citing papers authored by Shuiying Hu

Since Specialization
Citations

This map shows the geographic impact of Shuiying Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuiying Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuiying Hu more than expected).

Fields of papers citing papers by Shuiying Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuiying Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuiying Hu. The network helps show where Shuiying Hu may publish in the future.

Co-authorship network of co-authors of Shuiying Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Shuiying Hu. A scholar is included among the top collaborators of Shuiying Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuiying Hu. Shuiying Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 2
4 3
5 7
6 5
7 5
8 27
9 7
10 26
11 46
12 38
13 47
14 131
15 52
16 76
17 54
18 129
19 31
20 59

About Shuiying Hu

Shuiying Hu is a scholar working on Oncology, Pharmacology and Hematology, having authored 94 papers that have together received 3.5k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (44 papers), Pharmacogenetics and Drug Metabolism (17 papers) and Cancer Treatment and Pharmacology (16 papers). The work is most often cited by research in Oncology (1.7k citations), Hematology (505 citations) and Endocrinology, Diabetes and Metabolism (696 citations). Shuiying Hu has collaborated with scholars based in United States, Netherlands and Italy. Frequent co-authors include Alex Sparreboom, Sharyn D. Baker, Mingzhao Xing, Shelley Orwick, Alice A. Gibson, Dingxie Liu, Peng Hou, Vasily Vasko, Lie Li and Ryan M. Franke. Their work appears in journals such as Proceedings of the National Academy of Sciences, Circulation and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026